Brand loyalty, entry, and price competition in pharmaceuticals after the 1984 Drug Act

Article Abstract:

The 1984 Drug Price Competition and Patent Term Restoration Act succeeded in spreading competition among generic drugs to enable lower prices for consumers. A study of 18 products from 1984 to 1988 gives statistical support for the law's effectiveness, while showing that pricing strategies were not employed by the original product companies to hinder the success of generics. However, there have been revenue losses to companies with products in later stages of patent life.

Generic drugs

---

Economics and politics: the case of sugar tariff reform

Article Abstract:

The authors examine congressional voting in 1912 on the reform of the sugar tariff to determine political influences on trade policy. Results indicate sugar beet and sugarcane laborers and farmers were more politically active in the creation of protective tariffs than shareholders.

United States, Political activity, International trade, Political aspects, Sugar industry, Sugar, Agriculture and politics, Agricultural politics, Agricultural laborers, Farmers, Tariffs

---

Gradual incorporation of information: pharmaceutical stocks and the evolution of President Clinton's health care reform

Article Abstract:

President Bill Clinton's health care reform plan caused a gradual decline in stock prices in the pharmaceutical industry. The industry believed that pharmaceutical prices would fall even in the absence of direct price controls.

Analysis, Stock prices, Health care reform, 1992 AD, 1993 AD

Similar abstracts:

• Abstracts: Double blind lawmaking and other comments on formalism in the tax law. Formalism and realism in Commerce Clause jurisprudence
• Abstracts: Preclusive abstention: issue preclusion and jurisdictional dismissals after Ruhrgas
• Abstracts: What is an employer benefit plan? ERISA preemption of "any willing provider" law after Pegram. Peonage and contractual liberty
• Abstracts: Racial, ethnic, and gender disparities in sentencing: evidence from the U.S. federal courts. Reversion taxes, contingent benefits, and the decline in pension funding

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.